multiple myeloma
September 16, 2020
UAMS Researcher Delgado-Calle Awarded $1.7 Million to Study Bone Health in Myeloma Patients
LITTLE ROCK —Jesus Delgado-Calle, Ph.D., an assistant professor at the University of Arkansas for Medical Sciences (UAMS), has been awarded a National Cancer Institute grant of more than $1.7 million to study ways bone therapy might repair damaged bone and prevent or delay relapse in myeloma patients. Multiple myeloma, a cancer of the plasma cells…
March 2, 2017
U.S. Ambassador Chooses UAMS Myeloma Institute
March 2, 2017 | Ambassador Ruth A. Davis traveled the world as a U.S. diplomat during her 40 years with the U.S. Foreign Service. But when she learned she had a relapse of multiple myeloma, a cancer of plasma cells in the blood, she headed to Arkansas and the UAMS Myeloma Institute. “I’ve often had…
March 2, 2015
Celgene Gives $10 Million to Myeloma Institute
March 2, 2015 | The Myeloma Institute at the University of Arkansas for Medical Sciences (UAMS) has received a generous gift from Celgene Corporation to benefit patients with multiple myeloma through the creation of The Bart Barlogie Center for Molecular Diagnostics and the establishment of the Celgene Distinguished Endowed Chair in Molecular Therapeutics.
Celgene Gift to UAMS Myeloma Institute for Bart Barlogie Center for Molecular Diagnostics Advances the Course of Human Health for Patients with Multiple Myeloma
LITTLE ROCK –The Myeloma Institute at the University of Arkansas for Medical Sciences (UAMS) has received a generous gift from Celgene Corporation to benefit patients with multiple myeloma through the creation of The Bart Barlogie Center for Molecular Diagnostics and the establishment of the Celgene Distinguished Endowed Chair in Molecular Therapeutics.
April 22, 2014
Internationally Known Multiple Myeloma Expert Gareth Morgan, M.D., Ph.D., Coming to Lead UAMS Myeloma Institute
April 22, 2014 | World-renowned multiple myeloma researcher and clinician Gareth Morgan, M.D., Ph.D., today was named director of the University of Arkansas for Medical Sciences (UAMS) Myeloma Institute for Research and Therapy (MIRT).
Internationally Known Multiple Myeloma Expert Gareth Morgan, M.D., Ph.D., Coming from London to Lead UAMS Myeloma Institute
LITTLE ROCK – World-renowned multiple myeloma researcher and clinician Gareth Morgan, M.D., Ph.D., today was named director of the University of Arkansas for Medical Sciences (UAMS) Myeloma Institute for Research and Therapy (MIRT).
December 12, 2012
New High-Tech Tool Aids Hunt for Myeloma Cure
Dec. 12, 2012 | Understanding genetic processes in plasma cells may present a promising opportunity to develop new targeted treatments for multiple myeloma, and UAMS Myeloma Institute for Research and Therapy researchers have a new tool that will enable, for the first time, detailed examination of these processes.
July 11, 2012
Johann, Oncologist and Proteomics Researcher, Joins UAMS Myeloma Institute
<span class=”content”>LITTLE ROCK – Fellowship-trained hematologic oncologist and proteomics researcher Donald J. Johann Jr., M.D., has joined the Myeloma Institute for Research and Therapy at the University of Arkansas for Medical Sciences (UAMS). </span>
May 7, 2012
Long-Term Myeloma Survivors Gather for ‘Family Reunion’
May 7, 2012 | Ray Washtak vividly remembers his first visit to the Myeloma Institute for Research and Therapy (MIRT) at UAMS in 1991.
November 10, 2011
Myeloma Institute Reaches 10,000 Patients Mark
Nov. 10, 2011 | The internationally known Myeloma Institute for Research and Therapy at the University of Arkansas for Medical Sciences (UAMS) marked another milestone Nov. 9, treatment of the 10,000th patient in its 22-year history.
Next page